{
    "cancer_info": {
        "cancer_name": "Lung Cancer"
    },
    "diagnosis_recommendations": {
        "examinations": [
            "Low-Dose CT (LDCT)",
            "Chest CT with IV contrast (for mediastinal abnormalities)",
            "FDG PET-CT (for nodules ≥8 mm solid component)",
            "Transthoracic needle biopsy (TTNB)",
            "Surgical excision",
            "Quantitative perfusion CT",
            "Volume Doubling Time (VDT) analysis"
        ]
    },
    "staging_treatment_plans": [
        {
            "staging_criteria": "Stage I NSCLC",
            "risk_group": "Operable",
            "treatment_plans": [
                {
                    "treatment_line": "Curative-intent",
                    "patient_subgroup": "Surgical candidates",
                    "plan_name": "Lobectomy",
                    "plan_details": "Video-Assisted Thoracoscopic Surgery (VATS) preferred over thoracotomy",
                    "nccn_evidence_category": null,
                    "nccn_recommendation_category": null
                }
            ]
        },
        {
            "staging_criteria": "Stage I NSCLC",
            "risk_group": "Medically inoperable",
            "treatment_plans": [
                {
                    "treatment_line": "Curative-intent",
                    "patient_subgroup": "Non-surgical candidates",
                    "plan_name": "Stereotactic Ablative Radiotherapy",
                    "plan_details": "SABR/SBRT",
                    "nccn_evidence_category": null,
                    "nccn_recommendation_category": null
                },
                {
                    "treatment_line": "Curative-intent",
                    "patient_subgroup": "High-risk patients",
                    "plan_name": "Ablative Techniques",
                    "plan_details": "RFA, microwave, cryoablation",
                    "nccn_evidence_category": null,
                    "nccn_recommendation_category": null
                }
            ]
        },
        {
            "staging_criteria": "Stage III NSCLC",
            "risk_group": "Advanced",
            "treatment_plans": [
                {
                    "treatment_line": "First-line",
                    "patient_subgroup": "Locally advanced",
                    "plan_name": "Chemoradiation ± surgery",
                    "plan_details": "Combined modality therapy",
                    "nccn_evidence_category": null,
                    "nccn_recommendation_category": null
                }
            ]
        }
    ],
    "biomarker_clinical_significance": {
        "clinical_significance": [
            "Nodule Growth Rate (VDT): <400 days suggests malignancy",
            "PET-CT SUVmax: Higher uptake correlates with malignancy",
            "Adenocarcinoma subtypes (lepidic, acinar) predict survival",
            "CHRNA5 variants associated with nicotine dependence and lung cancer risk",
            "COPD/emphysema detection on CT is independent risk factor",
            "Coronary Artery Calcification (CAC) predicts cardiovascular risk"
        ]
    },
    "guideline_id": "（2025.V1）NCCN临床实践指南：肺癌筛查.txt"
}